يعرض 11 - 20 نتائج من 220 نتيجة بحث عن '"von Lilienfeld-Toal, M"', وقت الاستعلام: 1.08s تنقيح النتائج
  1. 11
    دورية أكاديمية
  2. 12
    دورية أكاديمية
  3. 13
  4. 14
    دورية أكاديمية

    المصدر: INFECTION

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37434025; http://hdl.handle.net/21.11116/0000-000D-7EAA-7Test

  5. 15
    دورية أكاديمية
  6. 16
    دورية أكاديمية
  7. 17
    دورية أكاديمية
  8. 18
    دورية أكاديمية
  9. 19
    مؤتمر
  10. 20
    مؤتمر

    المؤلفون: Rachow, T, von Lilienfeld-Toal, M

    المصدر: Bad Honnef-Symposium 2016; 20160321-20160322; Bonn; DOC16bhs11 /20160316/

    مصطلحات موضوعية: ddc: 610

    العلاقة: Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013;98(12):1826-35.; Bow EJ, Rotstein C, Noskin GA, Laverdiere M, Schwarer AP, Segal BH, et al. A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. Clin Infect Dis. 2006;43(4):447-59.; Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(6):794-810.; Sime FB, Roberts MS, Tiong IS, Gardner JH, Lehman S, Peake SL, et al. Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial. J Antimicrob Chemother. 2015;70(8):2369-75.; http://dx.doi.org/10.3205/16bhs11Test; http://nbn-resolving.de/urn:nbn:de:0183-16bhs118Test; http://www.egms.de/en/meetings/bhs2016/16bhs11.shtmlTest